Furthermore, a retrospective cohort analysis showed that 19 patients/1,000 patient-years suffered a cardiovascular event in subjects receiving insulin therapy compared with 22/1,000 patient-years in subjects receiving non-insulin treatment, which indicates that insulin treatment may be related to reduced risk of atherosclerotic outcomes in type 2 diabetes (3). The gene discussed is INS; the disease is type 2 diabetes mellitus.